Genetics of emergent suicidality during antidepressive treatment—Data from a naturalistic study on a large sample of inpatients with a major depressive episode

[1]  F. Holsboer,et al.  Genome-Wide Association Study of Antidepressant Treatment-Emergent Suicidal Ideation , 2012, Neuropsychopharmacology.

[2]  Abraham Weizman,et al.  Association of polymorphisms of the serotonergic pathways with clinical traits of impulsive-aggression and suicidality in adolescents: A multi-center study , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[3]  M. Rietschel,et al.  Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project , 2010, The Pharmacogenomics Journal.

[4]  G. Turecki,et al.  Pharmacogenomics of suicidal events. , 2010, Pharmacogenomics.

[5]  H. Möller,et al.  Review: antidepressants associated with increased risk of suicidality in adults aged less than 25 years , 2010, Evidence Based Mental Health.

[6]  H. Möller,et al.  Outcomes of 1014 naturalistically treated inpatients with major depressive episode , 2010, European Neuropsychopharmacology.

[7]  B. Devlin,et al.  Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. , 2010, The American journal of psychiatry.

[8]  T. Lehtimäki,et al.  TPH2 polymorphisms may modify clinical picture in treatment-resistant depression , 2009, Neuroscience Letters.

[9]  D. Brent.  In search of endophenotypes for suicidal behavior. , 2009, The American journal of psychiatry.

[10]  F. McMahon,et al.  Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients , 2009, Pharmacogenetics and genomics.

[11]  M. Rietschel,et al.  Genetic Predictors of Increase in Suicidal Ideation During Antidepressant Treatment in the GENDEP Project , 2009, Neuropsychopharmacology.

[12]  V. Carli,et al.  Brain derived neurotrophic factor (BDNF) genetic polymorphism (Val66Met) in suicide: A study of 512 cases , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[13]  S. Roche,et al.  Support for tryptophan hydroxylase-2 as a susceptibility gene for bipolar affective disorder. , 2009, Psychiatric genetics.

[14]  A. Wenzel,et al.  Candidate Endophenotypes for Genetic Studies of Suicidal Behavior , 2009, Biological Psychiatry.

[15]  H. Möller,et al.  The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode. , 2009, The international journal of neuropsychopharmacology.

[16]  H. Möller,et al.  Antidepressants and suicidality in younger adults – is bipolar illness the missing link? , 2009, Acta Psychiatrica Scandinavica.

[17]  Sven Cichon,et al.  Investigation of the tryptophan hydroxylase 2 gene in bipolar I disorder in the Romanian population , 2008, Psychiatric genetics.

[18]  F. Holsboer,et al.  Genetic markers within glutamate receptors associated with antidepressant treatment-emergent suicidal ideation. , 2008, The American journal of psychiatry.

[19]  A. Roy,et al.  Association of Polymorphism (Val66Met) of Brain-Derived Neurotrophic Factor with Suicide Attempts in Depressed Patients , 2008, Neuropsychobiology.

[20]  E. Ryding,et al.  Serotonin transporter gene polymorphisms: Effect on serotonin transporter availability in the brain of suicide attempters , 2008, Psychiatry Research: Neuroimaging.

[21]  M. Leboyer,et al.  Interaction between BDNF Val66Met and childhood trauma on adult’s violent suicide attempt , 2008, Genes, brain, and behavior.

[22]  Alexander F. Wilson,et al.  Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. , 2007, The American journal of psychiatry.

[23]  S. Cichon,et al.  Brain-specific tryptophan hydroxylase 2 (TPH2): a functional Pro206Ser substitution and variation in the 5'-region are associated with bipolar affective disorder. , 2007, Human molecular genetics.

[24]  T. Lai,et al.  Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han Chinese. , 2007, Archives of general psychiatry.

[25]  M. Fava,et al.  Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. , 2007, Archives of general psychiatry.

[26]  N. Barden,et al.  Polymorphisms in the neuronal isoform of tryptophan hydroxylase 2 are associated with bipolar disorder in French Canadian pedigrees , 2007, Psychiatric genetics.

[27]  Hans-Jürgen Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[28]  K. Hornik,et al.  Unbiased Recursive Partitioning: A Conditional Inference Framework , 2006 .

[29]  D. Goldman,et al.  Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. , 2005, Archives of general psychiatry.

[30]  P. Courtet,et al.  The monoamine oxidase A gene may influence the means used in suicide attempts , 2005, Psychiatric genetics.

[31]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[32]  H. Möller,et al.  SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression , 2004, Molecular Psychiatry.

[33]  H. Möller,et al.  Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase Isoform (TPH2) gene in suicide victims , 2004, Biological Psychiatry.

[34]  B. Bondy,et al.  Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains , 2004, European Neuropsychopharmacology.

[35]  D. Rujescu,et al.  Genetic variations in tryptophan hydroxylase in suicidal behavior analysis and meta-analysis , 2003, Biological Psychiatry.

[36]  M. Palkovits,et al.  High activity-related allele of MAO-A gene associated with depressed suicide in males , 2002, Neuroreport.

[37]  H. Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder , 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[38]  P. Hrdina,et al.  Serotonergic genes and suicidality. , 2000, Crisis.

[39]  C. Beasley,et al.  Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. , 1991, BMJ.

[40]  U. Ahlfors,et al.  The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients , 1987, Acta psychiatrica Scandinavica. Supplementum.

[41]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[42]  M. Hamilton,et al.  Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.

[43]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[44]  David Goldman,et al.  An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. , 2005, Alcoholism, clinical and experimental research.

[45]  F. Bellivier,et al.  Association between the TPH gene A218C polymorphism and suicidal behavior: A meta‐analysis , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[46]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..

[47]  J. Markowitz,et al.  Background information and treatment recommendations for patients with HIV/AIDS , 2000 .

[48]  H. Wittchen,et al.  SKID I. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. Interviewheft und Beurteilungsheft. Eine deutschsprachige, erweiterte Bearb. d. amerikanischen Originalversion des SKID I , 1997 .

[49]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .